AIM ImmunoTech Inc.
AIMNYSECIK 946644HealthcareFiscal year ends Dec 31
Reports and events: 415 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-3016:05 ET | DEF 14A | Proxy statementPeriod 2026-09-30 | 0001493152-26-045102 |
| 2026-09-1416:35 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-042592 |
| 2026-09-1016:35 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-042196 |
| 2026-09-0416:05 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-041537 |
| 2026-08-1108:40 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036996 |
| 2026-08-1008:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-036753 |
| 2026-08-0716:35 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-036609 |
| 2026-08-0617:22 ET | 8-K | 1.01 Entry into a material agreement; 5.08 Item not in the standard list; 9.01 Financial statements and exhibits | 0001493152-26-036408 |
| 2026-08-0508:00 ET | 8-K | 1.02 Termination of a material agreement | 0001493152-26-036104 |
| 2026-07-1616:05 ET | 8-K | 5.07 Shareholder vote results | 0001493152-26-033514 |
| 2026-06-2508:55 ET | DEF 14A | Proxy statementPeriod 2026-06-25 | 0001493152-26-030043 |
| 2026-06-1808:00 ET | S-1 | Registration statement | 0001493152-26-029193 |
| 2026-06-1508:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-028615 |
| 2026-06-1116:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-028283 |
| 2026-06-1016:59 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-028129 |
| 2026-06-0816:05 ET | S-1 | Registration statement | 0001493152-26-027714 |
| 2026-06-0409:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-027210 |
| 2026-05-2111:31 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-024760 |
| 2026-05-1908:03 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-024353 |
| 2026-05-1516:05 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-023750 |
| 2026-05-1408:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-022891 |
| 2026-05-1216:27 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-022499 |
| 2026-05-0808:50 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-021863 |
| 2026-04-1016:33 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-016179 |
| 2026-03-2717:30 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-013301 |
| 2026-03-0617:15 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-009190 |
| 2026-02-1016:35 ET | S-1/A | Registration statement, amended | 0001493152-26-005975 |
| 2026-02-0508:40 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-005208 |
| 2026-01-2916:31 ET | S-1/A | Registration statement, amended | 0001493152-26-004238 |
| 2026-01-2312:53 ET | S-1/A | Registration statement, amended | 0001493152-26-003343 |
| 2026-01-2007:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-002728 |
| 2026-01-1217:19 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-001898 |
| 2025-12-1716:30 ET | 8-K | 5.07 Shareholder vote results | 0001493152-25-028156 |
| 2025-12-1218:21 ET | S-1 | Registration statement | 0001493152-25-027319 |
| 2025-11-1907:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-25-024156 |
| 2025-11-1716:36 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-023894 |
| 2025-10-2917:16 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-020102 |
| 2025-10-2916:30 ET | DEF 14A | Proxy statementPeriod 2025-10-29 | 0001493152-25-020083 |
| 2025-10-2009:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-018583 |
| 2025-08-1416:15 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001493152-25-011986 |
| 2025-07-3116:45 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-021762 |
| 2025-07-2809:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-011441 |
| 2025-07-2213:21 ET | S-1/A | Registration statement, amended | 0001641172-25-020534 |
| 2025-07-1515:05 ET | S-1/A | Registration statement, amended | 0001493152-25-011234 |
| 2025-06-2016:30 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-015861 |
| 2025-06-1216:50 ET | 8-K | 3.01 Delisting notice; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-014899 |
| 2025-05-1516:45 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-011033 |
| 2025-05-0120:23 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-007954 |
| 2025-04-0717:56 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-002858 |
| 2025-04-0410:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-002702 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 12:13 ET. Listed shows no prices and gives no investment advice.